Fact CheckerSign in

NCT05147701RecruitingPhase 1

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for NAION

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for the Treatment of Non-arteritic Ischemic Optic Neuropathy

Source: ClinicalTrials.gov · Last updated 16 Oct 2026

Brief summary (registry, in English)

This trial will study the safety and efficacy of intranasal delivery of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes for the treatment of non-arteritic ischemic optic neuropathy

Status (registry)
Recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
First submitted
29 Nov 2021
Start date
1 Feb 2022
Primary completion date
Jan 2028
Lead sponsor
The Foundation for Orthopaedics and Regenerative Medicine
NCT number
NCT05147701

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 20
  • From 1 Feb 2022 to the primary completion date, Jan 2028
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Continued drug abuse
  • Previous organ transplant

Other illness

  • Active infection
  • Active cancer
  • Chronic multisystem organ failure
  • Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
  • Hypersensitivity to sulfur

Lab values

  • Clinically significant Abnormalities on pre-treatment laboratory evaluation

Other

  • Pregnancy
  • Pre-menopausal women not using contraception

Who the study is looking for

  • Diagnosis of NAION (non-arteritic ischemic optic neuropathy)
  • Understanding and willingness to sign a written informed consent document

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prodromos Stem Cell Institute
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Prodromos Stem Cell Institute
Coordinator of this site? Confirm its status
NaplesUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.